- Home
- PLRX vs GDO Comparison
PLRX vs GDO Comparison
Compare PLRX & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLRX | GDO |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.6M | 80.2M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PLRX | GDO |
|---|---|---|
| Price | $1.11 | $10.55 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 620.5K | 28.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $10.52 |
| 52 Week High | $1.95 | $12.15 |
Technical Indicators
Market Signals| Indicator | PLRX | GDO |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 37.24 |
| Support Level | N/A | N/A |
| Resistance Level | $1.37 | $10.86 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 25.00 | 6.45 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.